Yvette Dancel
Family · Vineland, NJNPI 1780309252
Payments from drug & device makers
Across 102 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$451
- Otsuka America Pharmaceutical, Inc.$225
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$202
- Axsome Therapeutics, Inc.$105
- AstraZeneca$77
- Lilly USA, LLC$52
- plus $362 from 16 others
What the payments were for
- Food & beverage$1,46299%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $451 |
| Otsuka America Pharmaceutical, Inc. | 13 | $225 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $202 |
| Axsome Therapeutics, Inc. | 6 | $105 |
| AstraZeneca | 5 | $77 |
| Lilly USA, LLC | 3 | $52 |
| Sage Therapeutics, LLC | 3 | $46 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Novo Nordisk | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Exact Sciences | 1 | $29 |
| Alkermes, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Pfizer | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,475 in reported general payments places this provider in the 80th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 63 | $56,454 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $42,558 |
| JanuviaSitagliptin Phosphate | 59 | $41,258 |
| OzempicSemaglutide | 39 | $35,804 |
| VraylarCariprazine Hcl | 19 | $25,787 |
| EliquisApixaban | 29 | $25,438 |
| FarxigaDapagliflozin Propanediol | 33 | $20,312 |
| TradjentaLinagliptin | 11 | $15,861 |
| MounjaroTirzepatide | 14 | $15,705 |
| XareltoRivaroxaban | 18 | $15,705 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 80 | $7,886 |
| BrilintaTicagrelor | 15 | $6,240 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $6,146 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $5,868 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $34 | $35,80439 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $77 | $32,42074 claims |
| AbbVieVraylar | $451 | $25,78719 claims |
| PfizerEliquis | $18 | $25,43829 claims |
| Lilly USA, LLCMounjaro | $52 | $15,70514 claims |
| GSKBreo Ellipta, Incruse Ellipta | $16 | $11,07229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,692 family providers in New Jersey.
Other family in Vineland
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- Angie GarciaWest New York$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.